Axolabs is the leading Custom Research Organization for the discovery and preclinical drug development of oligonucleotide therapeutics and other nucleic acid medicines. Based on our world-leading know-how and 20 years of experience we provide high-end preclinical solutions tailored to our clients’ specific needs.

As Axolabs is part of the LGC group Axolabs’ customers benefit from additional resources and expertise right across LGC, including a wide range of analytical services, leading capabilities in CMC, GMP and research-grade oligonucleotide manufacturing as well as custom synthesis of specialty phosphoramidites and solid supports.